WHO ICTRP trial
A 24 month, multi-center, open-label, randomized, controlled study to evaluate…
NL-OMON37144 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON37144 |
|---|---|
| Public title | A 24 month, multi-center, open-label, randomized, controlled study to evaluate the efficacy and safety of concentration controlled everolimus to eliminate or to reduce tacrolimus compared to tacrolimus in de novo liver transplant recipients. |
| Scientific title | A 24 month, multi-center, open-label, randomized, controlled study to evaluate the efficacy and safety of concentration controlled everolimus to eliminate or to reduce tacrolimus compared to tacrolimus in de novo liver transplant recipients. - Evaluation of efficacy and safety of Certican versus… |
| Primary sponsor | Novartis |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | Netherlands |
| Conditions | Impaired renal function after liver transplantation;10019654;10038430;Impaired renal function after liver transplantation |
| Interventions | Group 1 (elimination arm): low dose Prograft until month 4 (then elimination) + Certican + steroids Group 2 (minimalisation arm): low dose Prograft + Certican + steroids Group 3 (control arm): standard treatment Prograft + steroids… |
| Registration date | Nov 1, 2011 |
| Target size | 30 |
| Secondary IDs | 2007-001821-85;NL20355.078.07 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: